These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8021791)

  • 41. Differences in the immunogenicity of three Haemophilus influenzae type b conjugate vaccines in infants.
    Granoff DM; Anderson EL; Osterholm MT; Holmes SJ; McHugh JE; Belshe RB; Medley F; Murphy TV
    J Pediatr; 1992 Aug; 121(2):187-94. PubMed ID: 1640282
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Haemophilus influenzae type b polysaccharides-protein conjugate vaccine elicits a more diverse antibody repertoire in infants than in adults.
    Adderson EE; Wilson PM; Cunningham MW; Shackelford PG
    J Immunol; 1998 Oct; 161(8):4177-82. PubMed ID: 9780191
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Safety and immunogenicity of a Haemophilus influenzae type B polysaccharide-tetanus toxoid conjugate vaccine combined with diphtheria, tetanus and pertussis vaccines in Thai infants.
    Chotpitayasunondh T; Panpitpat C; Thisyakorn U; Furer E; Que JU; Hasler T; Cryz SJ
    Southeast Asian J Trop Med Public Health; 1997 Mar; 28(1):91-8. PubMed ID: 9322290
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of Haemophilus influenzae type b vaccines on the epidemiology of bacterial meningitis.
    Wenger JD
    Infect Agents Dis; 1993 Oct; 2(5):324-32. PubMed ID: 8173815
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Safety and immunogenicity of PRP-T combined with DTP: excretion of capsular polysaccharide and antibody response in the immediate post-vaccination period.
    Miller MA; Meschievitz CK; Ballanco GA; Daum RS
    Pediatrics; 1995 Apr; 95(4):522-7. PubMed ID: 7700752
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunogenicity of a fourth dose of Haemophilus influenzae type b (Hib) conjugate vaccine and antibody persistence in young children from the United Kingdom who were primed with acellular or whole-cell pertussis component-containing Hib combinations in infancy.
    Southern J; McVernon J; Gelb D; Andrews N; Morris R; Crowley-Luke A; Goldblatt D; Miller E
    Clin Vaccine Immunol; 2007 Oct; 14(10):1328-33. PubMed ID: 17699835
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reactogenicity and immunogenicity profiles of a novel pentavalent diphtheria-tetanus-whole cell pertussis-hepatitis B and Haemophilus influenzae type B vaccine: a randomized dose-ranging trial of the Hib tetanus-conjugate content.
    Hla KH; Thein SA; Aye A; Han HH; Bock HL; David MP; Schuerman L
    Pediatr Infect Dis J; 2006 Aug; 25(8):706-12. PubMed ID: 16874170
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Response of recent human immunodeficiency virus seroconverters to the pneumococcal polysaccharide vaccine and Haemophilus influenzae type b conjugate vaccine.
    Weiss PJ; Wallace MR; Oldfield EC; O'Brien J; Janoff EN
    J Infect Dis; 1995 May; 171(5):1217-22. PubMed ID: 7751696
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antibody response to immunization with Haemophilus influenzae type b polysaccharide vaccine in children with cancer.
    Weisman SJ; Cates KL; Allegretta GJ; Quinn JJ; Altman AJ
    J Pediatr; 1987 Nov; 111(5):727-9. PubMed ID: 3499501
    [No Abstract]   [Full Text] [Related]  

  • 50. Vaccine failures after primary immunisation with Haemophilus influenzae type-b conjugate vaccine without booster.
    Booy R; Heath PT; Slack MP; Begg N; Moxon ER
    Lancet; 1997 Apr; 349(9060):1197-202. PubMed ID: 9130940
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antibodies to Haemophilus influenzae type b polysaccharide affect bacterial adherence and multiplication.
    van Alphen L; Eijk P; Käyhty H; van Marle J; Dankert J
    Infect Immun; 1996 Mar; 64(3):995-1001. PubMed ID: 8641812
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High antibody responses to booster doses of either Haemophilus influenzae capsular polysaccharide or conjugate vaccine after primary immunization with conjugate vaccines.
    Käyhty H; Eskola J; Peltola H; Saarinen L; Mäkelä PH
    J Infect Dis; 1992 Jun; 165 Suppl 1():S165-6. PubMed ID: 1588156
    [No Abstract]   [Full Text] [Related]  

  • 53. Three-dose vaccination of infants under 8 months of age with a conjugate Haemophilus influenzae type B vaccine.
    Rowe JE; Messinger IK; Schwendeman CA; Popejoy LA
    Mil Med; 1990 Oct; 155(10):483-6. PubMed ID: 2122290
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A rapid and sensitive chemiluminescence assay for evaluation of functional opsonic activity of Haemophilus influenzae type b-specific antibodies.
    Ojo-Amaize EA; Church JA; Barka NE; Agopian MS; Peter JB
    Clin Diagn Lab Immunol; 1995 May; 2(3):286-90. PubMed ID: 7664173
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Haemophilus influenzae type b conjugate vaccine is highly effective in the Ugandan routine immunization program: a case-control study.
    Lee EH; Lewis RF; Makumbi I; Kekitiinwa A; Ediamu TD; Bazibu M; Braka F; Flannery B; Zuber PL; Feikin DR
    Trop Med Int Health; 2008 Apr; 13(4):495-502. PubMed ID: 18312475
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular ontogeny of the human antibody repertoire to the Haemophilus influenzae type B polysaccharide: expression of canonical variable regions and their variants in vaccinated infants.
    Lucas AH; McLean GR; Reason DC; O'Connor AP; Felton MC; Moulton KD
    Clin Immunol; 2003 Aug; 108(2):119-27. PubMed ID: 12921758
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of a regional Hib vaccination programme in Italy.
    Gallo G; Ciofi degli Atti ML; Cerquetti M; Piovesan C; Tozzi AE; Salmaso S
    Vaccine; 2002 Jan; 20(7-8):993-5. PubMed ID: 11803057
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antibody response of Mexican infants to Haemophilus influenzae type b capsular polyribosylribitol phosphate. Differences between natural and vaccine induced (oligosaccharide-CRM197 conjugated vaccine) immunization.
    Massó F; Paéz A; Arista A; Salmón L; Montaño L
    Arch Med Res; 1996; 27(4):539-45. PubMed ID: 8987192
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Age-dependent V region expression in the human antibody response to the Haemophilus influenzae type b polysaccharide.
    Lucas AH; Azmi FH; Mink CM; Granoff DM
    J Immunol; 1993 Mar; 150(5):2056-61. PubMed ID: 8436834
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antibodies to Haemophilus influenzae serotype b in the Netherlands a few years after the introduction of routine vaccination.
    van Den Hof S; de Melker HE; Berbers GA; van Der Kraak PH; Spaendonck MA
    Clin Infect Dis; 2001 Jan; 32(1):2-8. PubMed ID: 11118384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.